Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

5.92
Delayed Data
As of Jun 23
 +0.04 / +0.68%
Today’s Change
4.72
Today|||52-Week Range
9.72
+5.71%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close5.88
Today’s open5.89
Day’s range5.79 - 6.00
Volume181,716
Average volume (3 months)118,207
Market cap$149.8M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+18.45%
Earnings growth (this year)-4.82%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+140.14%
P/E ratio--
Price/Sales5.59
Price/Book2.33

Competitors

 Today’s
change
Today’s
% change
GNCAGenocea Biosciences ...+0.12+2.23%
COOLPolarityte Inc+3.87+16.09%
--Wang On Group Ltd-0.00-14.29%
PSTIPluristem Therapeuti...0.000.00%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 25, 2017
EPS forecast (this quarter)-$0.77
Annual revenue (last year)$25.1M
Annual profit (last year)-$73.4M
Net profit margin-292.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts